Local IL-4 Expression in the Lung Reduces Pulmonary Influenza-Virus-Specific Secondary Cytotoxic T Cell Responses  by Bot, Adrian et al.
I
p
a
e
c
a
c
b
q
t
v
s
t
t
t
t
w
d
Virology 269, 66–77 (2000)
doi:10.1006/viro.2000.0187, available online at http://www.idealibrary.com onLocal IL-4 Expression in the Lung Reduces Pulmonary Influenza-Virus-Specific
Secondary Cytotoxic T Cell Responses
Adrian Bot,* Andreas Holz,* Urs Christen,* Tom Wolfe,* Angela Temann,†
Richard Flavell,† and Matthias von Herrath*,1
*Department of Neuropharmacology, Division of Virology, IMM6, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California
92037; and †Section of Immunobiology, Howard Hughes Medical Institute, Yale University, New Haven, Connecticut 06520
Received July 30, 1999; returned to author for revision September 2, 1999; accepted January 5, 2000
We studied the effect of lung-specific IL-4 expression on the T cell response during primary and secondary heterologous
infection with influenza virus by using transgenic mice that express IL-4 under a lung-specific promoter. Subsequent to
primary infection with a type A/H1N1 influenza virus these transgenic mice exhibited similar local recruitment of CD41 and
CD81 T cells and only slightly decreased virus-specific CTL activity. However, during secondary challenge with a heterol-
ogous influenza virus, the local infiltration with virus-specific, MHC class I-restricted CD81 T cells was significantly
decreased compared to that of nontransgenic littermates. The ability of IL-4 transgenic mice to clear the heterologous
infection was delayed but not abrogated. This was associated with a faster virus-neutralizing antibody response in IL-4
transgenic mice and with their ability to mount significant Th1 responses even in the presence of increased local IL-4
expression. Our observations demonstrate a negative regulatory effect of IL-4 on memory Tc1/CD81 T cells, but are also
consistent with complementary mechanisms important for virus clearance such as virus-neutralizing antibodies. The
reduction of memory CTL in the presence of IL-4 might have consequences for understanding the course of influenza
infection in situations where TH2 immunity is increased. © 2000 Academic Press
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bINTRODUCTION
During immune responses to microbes, antigen-spe-
cific class I- and class II-restricted T cells as well as B
cells are primed and exert various defensive functions.
Early studies defined two subpopulations of functional
class II-restricted T helper (Th) cells: Th1 cells that pro-
duce IL-2 and IFN-g and Th2 cells that secrete IL-4 and
L-5 (Mosmann et al., 1986). Accumulating evidence sup-
orts the model that Th1 promoting cytokines like IL-12,
s well as Th1 cytokines like IFN-g, exert suppressive
ffects on the generation and activity of Th2 cells. In
ontrast, Th2 cytokines like IL-4 inhibit the generation
nd function of Th1 cells. Thus, during exposure to mi-
robial antigens, the initial pattern of cytokines produced
y cells of the innate immune system shape the subse-
uent adaptive response toward either Th1 or Th2. It is
hought that Th1 cells control effective immunity against
iruses. In contrast, Th2 cells generally promote re-
ponses that are unable to fully protect against infec-
ious challenge. This was previously demonstrated sys-
emically for influenza virus using a model of adoptive
ransfer with Th1 or Th2 clones (Graham et al., 1994). In
hese studies, transfer of the virus-specific Th2 clones
as followed by impaired responses against influenza
1 To whom correspondence and reprint requests should be ad-
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66irus. Since the Th2 clones produced multiple cytokines,
heir individual role in the suppression of immunity
gainst influenza virus was not clear.
We sought to investigate the role of IL-4 as a Th2
ytokine with potential regulatory function on class I-re-
tricted immunity. We took advantage of a transgenic
odel, where the IL-4 cDNA is locally expressed as a
ransgene under a lung-specific promoter, the rat Clara
ell protein 10 promoter (Rankin et al., 1996). The expres-
ion of IL-4 is restricted to lungs, specifically to the Clara
ells that comprise 50–70% of the epithelial cells in
rachea, bronchi, and bronchioles, known to be permis-
ive for infection with influenza virus. The assessment of
L-4 showed levels between 0.15 ng/ml and a few nano-
rams per milliliter in the broncho-alveolar lavage fluid,
ompared to less than 60 pg/ml to nondetectable levels
n sera. The transgenic mice displayed a certain degree
f epithelial hypertrophy, intra-alveolar macrophages,
nd occasional “islets” of eosinophils in the parenchyma
Rankin et al., 1996) that progressed with age (Jain-Vora
t al., 1997).
The immunity against influenza virus consists mainly
f B cells producing virus-neutralizing antibodies that
ind to hemagglutinin (HA) (Caton et al., 1982), Th cells
that recognize dominant class II-restricted epitopes on
HA (Haberman et al., 1990), and CTL specific for class
I-restricted epitopes on internal proteins, like nucleopro-
tein (NP) (Townsend and Bodmer, 1989). Whereas the
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67EFFECT OF LOCAL IL-4 ON T CELL RESPONSESantibodies and to a certain extent the Th cells recognize
epitopes that display increased variation among drift
variants and particularly among strains of different sub-
types, CTL recognize epitopes conserved among all type
A strains (Bastin et al., 1987). We have employed an
experimental model where IL-4 transgenic mice and
nontransgenic littermates were immunized via the intra-
peritoneal route with live A/HK/68 (H3N2) influenza virus
and challenged with the A/PR/8/34 (H1N1) strain. Since
the protective B cell epitopes as well as the dominant Th
epitopes are not conserved between these two strains,
the protection against infectious challenge depended
mostly on memory CTL against internal epitopes. Thus,
this experimental system could be used to assess the
effect of local expression of IL-4 on memory CD81 T cells
and their role in controlling pulmonary infection and
immunopathology.
We assessed the effect of lung-specific expression of
IL-4 on the primary and secondary immune response
under the conditions mentioned above. We found that
local expression of IL-4 exerted negative effects on
CD81 T cells during the secondary response to a heter-
ologous influenza virus. This was not due to a faster
clearance of virus by the IL-4 transgenic mice. Unexpect-
edly, Th1 cytokines were still significantly enhanced in
the lungs of the IL-4 transgenic mice infected with influ-
enza virus. Furthermore, de novo induction of protective
antibodies during infection was more rapid in the IL-4
transgenic mice, explaining why the virus clearance was
only delayed but not abrogated.
RESULTS
Primary influenza infection induces similar CTL levels
and immunopathology in IL-4 transgenic,
IL-4-deficient, or nontransgenic mice
HA of influenza virus bears dominant B and Th
epitopes, whereas NP carries the major CTL epitopes
(Caton et al., 1982; Townsend and Bodmer, 1989). Our
hypothesis was that expression of IL-4 in the lungs as a
transgene under the control of the lung-specific Clara 10
protein promoter (Rankin et al., 1996) would influence the
local T cell responses as well as viral clearance during
primary and/or secondary influenza infections. We tested
this hypothesis by infecting IL-4 transgenic mice, non-
transgenic littermates, and IL-42/2 mice with A/PR/8/34
(H1N1) influenza virus, followed by assessment of the
local T cell infiltration. We found that at day 7 after
primary infection, lungs of IL-4 transgenic mice dis-
played significant infiltration with CD41 and CD81 T
ells, comparable with nontransgenic littermates and
L-42/2 mice (Figs. 1A–1D). Noninfected IL-4 transgenic
ice exhibited rare CD41 and CD81 cells throughout the
lung parenchyma before the age of 3 months. Thus,
transgenic expression of IL-4 in the lung did not have
significant effects on the local infiltration with CD41 andCD81 T cells during the primary response to PR8 influ-
nza virus. The histology generally correlated with the
LISPOT analysis (Figs. 2B and 2D), with the single
mendment that the frequency of T cells producing cy-
okines upon polyclonal stimulation was reduced in the
ungs of IL-4 transgenic mice. The primary infection with
R8 was also followed by induction of significant virus-
pecific, class I-restricted T cell responses in lung (Figs.
B and 2D) and spleen (Figs. 3A and 3B). No significant
c1 to Tc2 switch was noted as a consequence of local,
onstitutive expression of IL-4 (Figs. 2A–2D). The sys-
emic responses of IL-42/2 and IL-4 tg mice were not
dramatically altered when compared to nontransgenic
littermates, except for an increased frequency of virus-
specific IL-4 and IFN-g producing T cells in the spleens
of IL-4 transgenic animals compared to nontransgenic
littermates (Figs. 2A and 2C). Furthermore, primary infec-
tion of IL-4 tg mice with a partial lethal dose of influenza
virus was followed by a survival rate that was not signif-
icantly reduced compared to that of littermates (4 of 6
versus 3 of 5; P . 0.05). Similar results were obtained
with a different H1N1 strain of influenza virus, A/WSN/32
(data not shown). Measurement of virus titers in the
nasal wash of IL-4 transgenic mice and littermates at day
5 after primary infection revealed no significant differ-
ences in virus levels or percentage of mice that showed
detectable infectious virus (IL-4 tg mice (5.0 6 0) 3 102
tissue culture infective dose 50% (TCID50)/ml, 100%; ver-
us littermates (5.0 6 2.4) 3 102 TCID50/ml, 80%). To-
ether, these data indicate that neither the specific T cell
esponses nor the overall protective responses are sig-
ificantly affected by local expression of IL-4 during pri-
ary infection with influenza viruses.
ung CD81 T cell numbers in response to
eterologous secondary influenza infection
re lower in IL-4 transgenic mice
Dominant B cell epitopes as well as class II-restricted
pitopes on HA recognized by CD41 Th cells are con-
served only among strains of influenza virus from the
same subtype. In contrast, the major class I-restricted
epitopes localized on NP and recognized by CD81 CTL
are extensively shared among type A strains of influenza
virus. Thus, by infecting intraperitoneally immunized
mice with a strain of a different subtype, one can test the
activation and recruitment of memory CD81 T cells to the
site of infection. We tested the effect of local expression
of IL-4 on the activity of memory CTL primed by ip
immunization with live A/HK/68 (H3N2) virus. Interest-
ingly, IL-4 transgenic mice immunized with HK virus and
infected 1 month later with influenza virus PR8 displayed
significantly reduced numbers of CD81 T cells in the
lungs on day 5 postinfection, compared to nontransgenic
littermates or C57BL/6 and IL-42/2 mice (Figs. 1E–1H
and 4). The density of the CD81 T cells as revealed by
w
t nd F c
I oup ar
68 BOT ET AL.immunohistochemistry was between 10 and 100 times
FIG. 1. CD41 and CD81 T cells in lungs of IL-4 transgenic and nontran
ere harvested on day 7 after primary infection (A–D) or day 5 after sec
o anti-CD4 staining and B, D, F, and H to anti-CD8 staining. A, B, E, a
L-4 transgenic mice. Representative data for at least three animals/grlower in the transgenic mice than in controls (Figs. 5 and
1H versus 1F). The analysis of the frequency of classI-restricted NP-specific T cells by ELISPOT showed sig-
mice during primary or secondary infection with influenza virus. Lungs
infection (E–H) and stained for CD4 or CD8. A, C, E, and G correspond
orrespond to nontransgenic littermates. C, D, G, and H correspond to
e shown.sgenic
ondarynificantly lower values in the lungs of IL-4 transgenic
mice versus nontransgenic littermates (Fig. 2F). How-
was pe
re indic
69EFFECT OF LOCAL IL-4 ON T CELL RESPONSESever, the difference was only three- to fourfold, which is
FIG. 4. Expression of CD30 in IL-4 transgenic mice, IL-42/2, mice
HK-immunized mice on day 5 after heterologous challenge with PR8
specific for CD4, CD8, and CD30. Mice and stain under observation aless than observed by immunohistochemical staining of
lung parenchyma. This quantitative discrepancy may bedue to two factors: the collagenase digestion cannot
ntransgenic littermates. Histological staining of lungs harvested from
rformed as described under Materials and Methods, using reagents
ated. The data shown are representative for three animals/group.and nodiscriminate between the parenchymal and BALT-de-
rived cells and second, the lung volume of IL-4 trans-
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70 BOT ET AL.genic mice was consistently two- to threefold higher than
that of nontransgenic littermates, due to IL-4-induced
hyperplasia (Rankin et al., 1996; Jain-Vora et al., 1997). No
down-regulation of specific CD81 T cells was noted in
he spleen (Fig. 3) and no significant Tc1 to Tc2 switch
ccurred in the IL-4 transgenic mice (Fig. 2). However,
he frequency of CD41 T cells infiltrating the lungs sub-
sequent to secondary infection with PR8 virus was only
slightly and infrequently decreased in the IL-4 transgenic
mice (Figs. 1E and 1G). The apparent decrease in the
local frequency of virus-specific IFN-g producing T cells
Fig. 2F) cannot be accounted for solely by a reduction of
D41 T cells and is probably due to the decreased
frequency of CD81 T cells. Overall, the balance of cyto-
FIG. 2. ELISPOT analysis of T cells from lungs or spleen of IL-4
transgenic and control mice, during primary (A–D) or secondary (E–H)
infection with influenza virus. Organs were harvested on day 7 (primary
infection) or 5 (secondary challenge) after infection and single-cell
suspensions of lymphocytes were prepared as described under Mate-
rials and Methods. Cells were stimulated with NP-Db peptide, PR8
irus, or anti-CD3 1 anti-CD28 antibodies, in nitrocellulose wells
oated with anti-IFN-g or anti-IL-4 antibodies. The analysis was devel-
ped after 72 h. The results are expressed as frequency (spots/106
responder cells) of IFN-g or IL-4 producing cells (means 6 SD, n 5 3
nimals/group).kines produced by the recruited T cells was slightly
shifted toward a Th2 profile, mainly due to decreased
rfrequency of virus-specific IFN-g producing T cells, but
not due to an increased frequency of IL-4 producing T
cells (Figs. 2F and 2H). Since dominant CTL epitopes like
the Db-restricted NP 366–374 are conserved among in-
fluenza virus strains of different subtypes (like H3N2 and
H1N1), this result shows a local negative effect of IL-4 on
primed CD81 T cells.
Consistent with the ELISPOT analysis, the measure-
ent of systemic secondary CTL responses in spleens
f IL-4 tg mice primed with HK and challenged with PR8
irus revealed no significant differences compared to the
roup of littermates (Fig. 3C). We further explored the
otential mechanism through which IL-4 can locally re-
uce influenza specific memory CTL. As shown in Fig. 4,
p-regulation of the CD30 antigen shown to be a potent
nhibitor of CD8 function (Kurts et al., 1999) that is ex-
FIG. 3. Induction of cytotoxic cells subsequent to primary (A, B) or
secondary (C) infection with influenza virus. Spleens were harvested on
day 7 (primary infection) or day 5 (secondary infection) from three
mice/group and splenocytes were in vitro stimulated with virus-infected
splenocytes. Subsequently, standard 51Cr-release assays were carried
ut. The specific lysis against B/Lee virus (A) or homologous virus (B,
) was measured at different responder/stimulator (R/S) ratios. Theesults are expressed as means 6 SEM of the percentage of specific
lysis measured individually.
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71EFFECT OF LOCAL IL-4 ON T CELL RESPONSESpressed on TH2 lymphocytes and CTL (Bengtsson et al.,
995; Kurts et al., 1999) was seen only in IL-4 transgenic
ice after infection with heterologous virus (Fig. 4, lower
iddle panel). No significant CD30 staining was noted in
he lungs of noninfected transgenic or nontransgenic
ice.
learance of secondary influenza infection is delayed
ut not abrogated in IL-4 transgenic mice
Determining viral titers in lungs and nasal washes
ssessed the effect of local transgenic expression of IL-4
n the ability of the immune system to clear a secondary
eterologous influenza infection. Fifty percent of the IL-4
ransgenic mice that were previously primed with HK
irus and subsequently infected with PR8 virus displayed
ne log lower viral titers in lungs at day 7 after infection
ompared to nonimmunized, nontransgenic mice (Table
). None of the immunized nontransgenic littermates or
L-42/2 mice displayed detectable viral titers at day 7
hen similarly infected. These results show a signifi-
antly delayed clearance of influenza virus in IL-4 trans-
enic mice after secondary infection with a strain of a
ifferent subtype (P , 0.05 by Fisher’s exact test, when
e compared the rate of virus detection in IL-4 trans-
enic mice versus pooled controls). When checked at
ay 5 for the presence of virus in the nasal cavity, the IL-4
ransgenic mice displayed higher virus titers than non-
ransgenic littermates (5.0 6 3.2 3 103 TCID50/ml vs
.8 6 2.0 3 102 TCID50/ml). By day 14 all survivors had
ompletely cleared the pulmonary virus (Table 1). In this
xperiment carried out with a 100% infectious dose, 6/6
ontransgenic and 5/6 IL-4 tg mice survived. Thus, the
ower number of CD81 T cells in the lungs of IL-4 trans-
genic mice was not a result of more rapid clearance of
influenza virus, but most probably the cause for the
impaired clearance of virus during the memory re-
T
Pulmonary Virus Titers during the Response of IL-4
Mice Immunization
C57BL/6 (n 5 3) None
C57BL/6 IL-42/2 (n 5 5) HK
Nontransgenic littermates
of IL-4 Tg (n 5 4)
HK
IL-4 transgenic (n 5 6) HK
a Pulmonary virus titers were measured at day 7 after infection and
b Number of mice displaying detectable virus levels/total number in
c Not done.
d No detectable pulmonary virus.
e One of six mice died on day 8.sponse. However, when compared to naive mice in-
fected with similar high doses of influenza virus, the IL-4 ftg mice previously immunized with HK displayed clear
tendencies to eliminate the pulmonary virus (Table 1).
This is consistent with compensatory clearance mecha-
nisms such as the de novo generation of neutralizing
antibodies.
Cytokine levels in lungs of IL-4 transgenic mice
We compared the expression of cytokines relative to
mRNA levels in lungs of HK-immunized animals, infected
or not with PR8 virus. We used nontransgenic littermates
as controls for the IL-4 transgenic mice. The assessment
of cytokine mRNAs in the lungs by RNase protection
assay confirmed increased levels of IL-4 mRNA in trans-
genic mice (Fig. 6A), consistent with previous data
(Rankin et al., 1996). Relative to the levels of IL-4 mRNA
in transgenic mice, the nontransgenic littermates exhib-
ited no significant expression. Surprisingly, local expres-
sion of IFN-g on day 5 after heterologous challenge was
ot decreased in uninfected or infected IL-4 transgenic
ice, compared to nontransgenic littermates. There was
FIG. 5. Comparison of lung infiltration during secondary response to
influenza virus between IL-4 transgenic and control mice. Lungs from
IL-4 transgenic mice, nontransgenic littermates, and IL-42/2 mice
were harvested on day 5 after heterologous infection and stained for
CD4 and CD8. For each animal, at least five different fields (objective
203) were screened for the presence and number of CD41 and CD81
T cells. The results were individually plotted in a logarithmic semiquan-
titative manner as follows: “1” corresponds to 1–10 cells/field; “2”
2 2 3
genic Mice after Primary Heterologous Challenge
tion
Pulmonary virus titersa
Day 7 Day 14
8 8.7 6 5.8 3 104(3/3)b NDc
8 0d (0/3) ND
8 0 (0/4) 0 (0/6)
8 2.0 6 0.9 3 103 (3/6) 0 (0/5)e
pressed as means 6 SEM of TCID50 per 2 ml of lung homogenate.
up.ABLE 1
Trans
Infec
PR
PR
PR
PR
are ex
the grocorresponds to 10–10 cells/field, and “3” corresponds to 10 –10 cells/
ield.
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72 BOT ET AL.a clear-cut tendency of IFN-g up-regulation upon infec-
ion in both transgenic and nontransgenic littermates
Fig. 6B). The expression of TNF-a increased upon infec-
tion, in the nontransgenic littermates. However, although
the basal levels of TNF-a expression were higher in the
L-4 transgenic mice than in nontransgenic littermates,
hey failed to increase upon infection (Fig. 6C). In con-
rast, only the IL-4 transgenic mice exhibited significant
p-regulation of IL-15 mRNA upon infectious challenge
Fig. 6D). IL-15 is thought to be produced mainly by
ntigen-presenting or stromal cells and has IL-2-like
ctivity, promoting the proliferation of recently activated T
ells (Johnston et al., 1995).
In conclusion and somewhat unexpectedly, local con-
stitutive expression of IL-4 did not abrogate the expres-
sion of IFN-g. However, the up-regulation of TNF-a sub-
equent to infection was prevented. Instead, IL-15 in-
reased subsequent to infection only in the IL-4
ransgenic mice. Increased basal levels of TNF-a may be
ue to the recruitment of natural immune cells as previ-
usly reported (Jain-Vora et al., 1997). The apparent dis-
repancy of the ELISPOT analysis with the results of
Nase protection assay regarding IFN-g expression may
be due to increased cytokine production on a per cell
basis, particularly since CD41 recruitment was only mod-
rately and inconsistently affected.
eutralizing antibodies specific for the secondary
eterologous influenza strain are increased
n IL-4 tg mice
FIG. 6. Expression of mRNA of various cytokines in the lungs of IL-4
RNase protection assays were individually carried out using lung tiss
infected (second set of bars) or HK-immunized and uninfected mice (fir
and quantified and the resulting signals were individually normalized
means 6 SEM of relative expression 3 1000. Black bars represent IL-4 tIn addition to the effector functions of T cells, neu-
ralizing antibodies that bind to HA and prevent attach-
b
hent to cellular receptors most probably play a role in
nfluenza virus clearance. Since transgenic expression
f IL-4 might increase the ability of B cells to prolifer-
te, differentiate, and produce specific antibodies, we
easured the titers of hemagglutination-inhibiting (HI)
ntibodies specific for the secondary virus (PR8) in
ice previously immunized with influenza (HK). Since
ffective mechanisms of protection should act during
he first week subsequent to infection with influenza
irus, we studied the HI titers early, on day 5 subse-
uent to the heterologous challenge. As shown in Fig.
A, IL-4 tg mice either primed or nonprimed with HK
irus mounted significantly higher HI-specific antibod-
es early during infection against the heterologous
train (PR8), when compared to littermates. The re-
ults are consistent with a more rapid onset of hu-
oral responses in the IL-4 tg mice. Most of the IL-4
ransgenic mice (5 of 6) displayed early detectable
iters of HI antibodies against the virus used for infec-
ion, in contrast to 0 of 7 nontransgenic littermates
P 5 0.01 of Fisher’s exact test). Slightly higher IgG
LISA titers were noted in the case of primed versus
onprimed IL-4 transgenic animals (data not shown),
ut they did not translate into significantly higher pro-
ective titers at day 5 (Fig. 7). However, on day 14 after
hallenge, the HI titers of both IL-4 transgenic and
ontransgenic mice were comparable, suggesting a
ifference in the kinetics but not magnitude of the
ntibody response (Fig. 7B). Together, these data sug-
est a compensatory role for virus-neutralizing anti-
enic mice and nontransgenic littermates after heterologous infection.
three mice/group harvested on day 5 from HK-immunized and PR8
f bars). The bands corresponding to protected mRNAs were scanned
tandard housekeeping message (L32). The results are expressed as
nic mice (“IL-4 Tg”); white bars represent nontransgenic controls (“Litt”).transg
ue from
st set oodies in IL-4 transgenic mice during the secondary
eterologous infection.
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73EFFECT OF LOCAL IL-4 ON T CELL RESPONSESDISCUSSION
We studied the effect of lung-specific IL-4 expression
n the local and systemic response against influenza
irus by using a previously described transgenic model
Rankin et al., 1996), in which IL-4 is selectively ex-
ressed under the Clara cell protein 10 promoter. During
he secondary response against a heterologous strain of
nfluenza virus (PR8) the IL-4 transgenic mice displayed:
i) reduced numbers of CD81 T in the lungs; (ii) a reduced
requency of MHC class I-restricted IFN-g producing T
ells in the lungs; (iii) delayed but not abrogated clear-
nce of pulmonary virus; and (iv) faster de novo induction
f PR8-specific neutralizing antibodies, already detect-
ble at day 5 after infection. However, surprisingly, the
ocal expression of IFN-g was not abrogated in the IL-4
transgenic animals subsequent to primary or secondary
infection with influenza virus. This correlated with the
lack of switch of the T cell response toward a clear-cut
Th2 or Tc2 profile, as shown by both ELISPOT and RNase
protection assay. This may be due to quantitative factors,
for example, relatively decreased exposure to IL-4 in
compartments where priming or expansion of T cells
occurs. Alternatively, it may be due to a limited regulatory
effect of IL-4 during infection, due to simultaneous activ-
ity of other cytokines. The latter hypothesis is more likely,
since recent studies involving coexpression of IL-4 and
viral antigen by the same vector revealed only quantita-
tive effects on the pool of specific Tc1/CTL but no dra-
matic Th1 to Th2 or Tc1 to Tc2 shifts (Aung et al., 1999).
FIG. 7. Induction of virus-neutralizing antibodies in IL-4 transgenic
mice. Sera were harvested from IL-4 transgenic or nontransgenic
littermates, on day 5 and 14 after primary or secondary infection with
influenza virus. The titers of neutralizing antibodies against PR8 virus
were individually measured (n 5 3–5 mice/group) by hemagglutination
inhibition and the results are expressed as means 6 SE of end-point
titers, on a logarithmic scale. The results are representative of two
independent experiments. ND, not done.Thus, a relatively down-regulated class I-restricted T cell
response during the recall but not during the primary
v
tresponse suggested that the expansion and/or recruit-
ment of memory CTL directed against conserved
epitopes was affected by local IL-4 expression. This was
not simply due to a more rapid clearance of pulmonary
virus, as shown by virus titration measurements. How-
ever, a faster humoral response combined with the ro-
bust cytokine production comprising Th1 elements might
have compensated for the decreased expansion/recruit-
ment of influenza virus-specific CTL directed against
conserved class I epitopes. This correlates with the
ability of IL-4 transgenic mice to clear the pulmonary
virus. IL-4 may directly or indirectly act on CD81 T cells
at certain stages throughout their life span after they
encounter the antigen, by the following mechanisms:
(i) Inhibition of expansion of memory CTL in the inter-
stitial tissue or bronchial-associated lymphoid tissue.
This mechanism is supported by previous studies, show-
ing inhibition of IL-2 synthesis by IL-4 (Sad and Moss-
man, 1995) or down-regulation of antigen presentation
(Cua et al., 1996);
(ii) Inhibition of recruitment of specific memory CD81
T cells in the lung parenchyma subsequent to secondary
heterologous infection, due to the alteration of chemo-
kine/chemokine receptor patterns under modified cyto-
kine profiles (Li et al., 1999; Cerwenka et al., 1999);
(iii) Increased decline in the population of memory
D81 T cells recently restimulated with antigen.
Our findings show that CD30 is up-regulated only in
ungs of IL-4 transgenic mice but not in the IL-4-deficient
r nontransgenic littermates after secondary influenza
nfection. Since CD30 expression is a potent inhibitor of
D8 cell function (Kurts et al., 1999) induced in TH2-type
environments (Gilfillan et al., 1998), it could be one of the
main factors suppressing CD8 cell activity (Bowen et al.,
1996) in the IL-4 transgenic mice.
There are previous studies that pointed toward an
important role for IL-4 in the regulation of T cell re-
sponses. Disruption of the IL-4 gene in knockout mice is
associated with decreased Th2 responses (Kopf et al.,
1993). In contrast, low levels of IL-4, together with IL-2,
seem to exert a synergistic effect on the expansion of
virus-specific CTL (Bachmann et al., 1995). On the other
hand, in vitro exposure of influenza virus-specific CD81 T
cells to stimulator cells in the presence of Th2 clones
resulted in significant inhibition of CTL activity (Palladino
et al., 1991). Further, the adoptive transfer of influenza
virus-specific Th2 clones also failed to mediate protec-
tive effects (Graham et al., 1994). Last, systemic admin-
istration of high doses of IL-4 to mice infected with
influenza virus significantly decreased primary and sec-
ondary responses to influenza virus, probably by affect-
ing the expansion and local recruitment of CD81 CTL
Moran et al., 1996). Whereas the IL-4-treated, influenza
irus-infected mice displayed a delayed virus clearance,
heir ability to recover from infection was not abrogated.
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74 BOT ET AL.Other previous studies showed that systemic exposure
to IL-4 was associated with various degrees of inhibition
of protective antiviral responses, possibly due to down-
regulation of CTL activity (Andrew and Coupar, 1992;
Sharma et al., 1996). In contrast to these observations,
our experimental model of local IL-4 expression allowed
dissection of local (lung) from systemic effects of IL-4
during influenza infection. The results indicating quanti-
tative modifications regarding specific CTL were similar
to those obtained by another group, using a different
strategy for local IL-4 expression (Aung et al., 1999).
The cytokine as well as the antibody response might
ave contributed to the clearance of influenza virus by
he IL-4 transgenic mice. Previous studies showed that
L-4 does not necessarily preclude the generation of
roinflammatory cytokines (Erb et al., 1996; Powrie et al.,
993). These results are concordant with our surprising
inding regarding the limited effect of local IL-4 expres-
ion on IFN-g production, subsequent to heterologous
challenge. Furthermore, the local expression of IL-15, a
cytokine that has activity similar to that of IL-2, was
enhanced in the IL-4 transgenic mice compared to non-
transgenic mice. These findings have two implications:
first, they show that there are exceptions to the rule that
strong Th1 responses could not coexist with increased
levels of IL-4 and second, they pinpoint a potential mech-
anism that contributes to the recovery from virus infec-
tion, in the context of reduced local CTL activity. Such
protective mechanisms leading to influenza virus clear-
ance independent of CTL function were previously sug-
gested (Bot et al., 1998; Scherle et al., 1997; Topham et
al., 1996). The mechanisms that mediate such effects
remain elusive, but at least two might occur: (i) a direct
one that limits the virus replication in infected cells and
(ii) an indirect one, exerted by increased titers of protec-
tive antibodies that have the ability to clear the pulmo-
nary virus (Graham and Braciale, 1997). This last possi-
bility is directly supported by our data showing signifi-
cant virus neutralizing titers in IL-4 transgenic mice but
not littermates early after infection, when protective
mechanisms are likely to have a higher impact on the
outcome. This result may be explained by the direct
positive effect of IL-4 on local B cells specific for virus
HA, consistent with the classically described function of
IL-4 as a “B cell growth factor” (reviewed by Paul, 1991).
In summary, transgenic expression of IL-4 exerted
negative effects on the local function of memory CD81 T
cells during heterologous challenge with influenza virus.
This was associated with up-regulation of CD30 and a
delayed but not abrogated clearance of pulmonary virus
during secondary infection. Nevertheless, the limited in-
hibition of Th1-type cytokines together with a faster de
novo neutralizing antibody response contributed to the
ability of IL-4 transgenic mice to control the virus infec-
tion. Our findings indicate that influenza infection might
take a slightly more prolonged and severe course insituations where IL-4 expression is increased in the
lungs.
MATERIALS AND METHODS
Mice
IL-4 transgenic mice (IL-4 tg) that bear the IL-4 gene
controlled by the Clara cell protein 10 promoter (Rankin
et al., 1996) were bred onto the C57BL/6 background for
at least six generations and maintained by sister–brother
mating. As controls, we have used littermates that did not
bear the transgene, C57BL/6 as well as IL-4 knockout
mice (The Jackson Laboratories, Bar Harbor, ME), in
certain experiments. The IL-4 transgene was routinely
detected by PCR using primers specific for the inserted
construct, 59-CCCCAGCTAGTTGTCATCC-39 and 59-TAGT-
GCTCTTTAGGCTTTCC-39. The mice were housed under
specific pathogen-free conditions at the Animal Facility
of The Scripps Research Institute (La Jolla, CA). In most
of the experiments, we used mice younger than 10
weeks.
Viruses, immunization, and infection
We used three strains of influenza virus, A/HK/68
(H3N2), A/PR/8/34 (H1N1), and B/Lee/40, that were
grown on 10-day-old embryonated chicken eggs, as well
as one strain A/WSN/32 (H1N1) grown on MDBK cells.
The original viruses were obtained from the Mount Sinai
School of Medicine (New York, NY) or kindly provided by
Linda Sherman at The Scripps Research Institute. Mice
were immunized via the intraperitoneal route with allan-
toic fluid diluted in 100 ml of sterile PBS containing 1 3
104 TCID50 of HK. Primary infection was carried out with
5 3 104 TCID50 of PR8 virus by intranasal instillation with
a volume of 40 ml of allantoic fluid diluted in sterile PBS
after anesthesia with metofane. Secondary infection was
carried out with 1 3 106 TCID50 of PR8 virus. The sec-
ondary challenge was carried out 1 month after immuni-
zation. Mice were sacrificed at different intervals after
infection and various samples (lungs, spleen) were har-
vested. In certain cases, nasal washes and blood sam-
ples were obtained previous to euthanasia.
Measurement of virus titers
Mice were sacrificed 7 days after the infection, lungs
were harvested, homogenized, and resuspended in a
total volume of 2 ml, with sterile PBS. Serial 10-fold
dilutions of homogenate were incubated in triplicate for
1 h with trypsinized MDCK cells seeded 1 day previously
in 96-well flat-bottom plates. Complete RPMI–10% FCS
medium was added and the cells were incubated for 48 h
at 37°C in a humidified CO2 incubator. After incubation,
the supernatants were harvested and coincubated with
washed chicken red blood cells for 1 h at room temper-
ature, in 96-well U-bottom plates. The titers were com-
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75EFFECT OF LOCAL IL-4 ON T CELL RESPONSESputed by interpolation according to previously estab-
lished methods (Isobe et al., 1994), taking into consider-
tion the highest dilution of lung homogenate exhibiting
etectable hemagglutination. Data were expressed as
CID50/volume corresponding to the lungs (2 ml).
Nasal washes were carried out following anesthesia
ith metofane. Mice were instilled in a drop-wise man-
er with a total volume of 150 ml of sterile PBS. The nasal
luid was recovered on petri dishes, collected in sterile
ubes, and immediately stored at 280°C. The virus titers
ere measured as described above and the results were
xpressed as TCID50/ml.
Immunohistochemistry
Seven days after primary infection or 5 days after
secondary infection the mice were sacrificed following
anesthesia with halothane, by bleeding from the axillary
artery. The lungs were removed, submerged in resin
(TissueTek), and quick frozen on dry ice. Tissue sections
were prepared on a cryostat, placed on SuperFrost glass
slides, air-dried for 5 min, and fixed in 90% ethanol for 10
min at 4°C. The slides were air-dried again and blocked
with 2% FCS/PBS (20 min), followed by biotin and avidin
(10 min each) (VectaStain, Vector Laboratories). The sec-
tions were washed with PBS and incubated for 1 h at
room temperature with anti-CD4, anti-CD8 rat anti-
mouse antibodies (PharMingen, San Diego, CA; 1:200
RM4–5 and 1:200 Ly-3.2 1 1:200 Ly-2, respectively), or
nti-CD30 hamster anti-mouse antibody (1:100; PharM-
ngen). After being washed, the sections were incubated
ith biotin-conjugated anti-rat or anti-hamster antibodies
1:200) for 30 min at room temperature. The sections
ere washed again and incubated with avidin-horserad-
sh peroxidase (Vector ABC kit, Vector Laboratories) and
ubstrate (DAB). The substrate reaction was blocked
ith saline and the sections were counter-stained for 5
in with hematoxylin (Sigma). After a wash with saline,
he sections were mounted and read with a microscope.
ontrols carried out with secondary antibody showed
he lack of background.
ytotoxicity assays
Mice were sacrificed at day 7 after primary infection or
ay 5 after secondary infection and spleens were har-
ested. Single-cell suspensions were obtained by minc-
ng and passing through cell strainers. The red blood
ells were lysed with Tris hypotonic buffer and after a
ash, the splenocytes were resuspended in complete
0%–FCS RPMI, supplemented with 50 mM 5-mercapto-
ethanol and 10 U/ml of human rIL-2. Stimulator cells
were prepared from spleens harvested from mice of
similar genotype, irradiated, and infected for 1 h with PR8
influenza virus (m.o.i. 5 5), at 37°C in 1% BSA–DMEM.
After an extensive wash, the stimulator and responder
cells were coincubated in triplicate at various R/S ratiosin 96-well flat-bottom plates, at 37°C and 5% CO2. After 5
ays of incubation, EL-4 target cells (class I1 class II2),
oninfected or infected with virus (m.o.i. 5 5, at 37°C for
h, in DMEM–1% BSA) and labeled with 51Cr, were
dded to the effector cells (5 3 103 target cells/well).
upernatants were harvested after 4 h and radioactivity
as measured in a gamma-counter. The results were
xpressed as specific lysis for particular R/S ratios: [(re-
ease 2 spontaneous release)/(maximum release 2
pontaneous release)] 3 100 2 background against
oninfected target cells. The results provided by such an
xperimental set-up were a function of the initial fre-
uency as well as in vitro expansion of virus-specific
CTL.
RNase protection assay
Lung tissue was harvested on day 5 after secondary
infection, immersed in Trizol reagent (TriReagent, Molec-
ular Research Center, Inc.), and homogenized using a
tissue mincer. The total RNA was extracted with chloro-
form followed by isopropanol precipitation and washing
with ethanol. After assessment of RNA quantity and qual-
ity by spectrophotometry and electrophoresis, we have
hybridized the RNA overnight with labeled probes spe-
cific for a large array of cytokine messages, provided by
a commercial kit (Riboquant, MCK4-3 and MCK4-1;
Pharmingen). The RNase protection assay was carried
out according to the manufacturer’s instructions. The gel
was scanned using a STORM 860 Phospho Imaging
System (Molecular Dynamics) and the intensity of bands
corresponding to various protected mRNAs was quanti-
fied using ImageQuant Software (Molecular Dynamics).
The results were expressed in arbitrary units relative to
the mRNA level of a housekeeping message (L32).
ELISPOT analysis
Nitrocellulose-treated 96-well flat-bottom plates (Milli-
pore) were coated with anti-IFN-g or anti-IL-4 antibodies,
overnight at 4°C (4 mg/ml, in sterile PBS). The wells were
blocked with 10% FCS–RPMI for 1 h at 37°C. After being
washed with sterile PBS, syngeneic stimulator cells (3 3
105 cells/well) were coincubated with responder cells
threefold dilutions, beginning with 3 3 105 cells/well) in
the presence of complete FCS–RPMI medium supple-
mented with 20 U/ml of human rIL-2 and sucrose purified
PR8 virus (4 mg/ml), class I-restricted peptide (NP-Db
366–374 ASNENMETM), or a mixture of anti-CD3 (2 mg/
ml) 1 anti-CD28 (2 mg/ml) (PharMingen). As control, cells
were incubated without antigens but in the presence of
IL-2. The stimulator cells were mytomicin-treated spleno-
cytes prepared from animals of matched genotype. No
stimulator cells were added in the case of polyclonal
stimulation. Some responder cells were prepared by
lung digestion with collagenase (Sigma) for 1 h at 37°C,
subsequent to tissue fragmentation. The plastic adherent
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76 BOT ET AL.cells were removed by a 30-min incubation in petri
dishes, at 37°C. After 72 h of incubation at 37°C and
humidified atmosphere in the presence of 5% CO2, the
cells were washed off with 0.05% Tween–PBS and biotin-
conjugated anti-cytokine antibodies were added over-
night at 2 mg/ml in 0.1%–FCS 0.05% Tween–PBS. The
ntibody pairs were purchased from PharMingen. The
ells were washed again and incubated with 1:1000
treptavidin:peroxidase (Vector Laboratories) for 1 h at
oom temperature, followed by substrate reaction. The
pots were counted using a stereomicroscope, after the
eaction was stopped with tap water and the wells were
ir-dried. Three to four animals/group were individually
tudied.
emagglutination inhibition assay
The hemagglutination inhibition assay was carried out
fter treatment of sera with receptor destroying enzyme
RDE/neuraminidase; Sigma, St. Louis, MO) overnight at
7°C, in order to remove the nonspecific hemagglutina-
ion-inhibiting activity due to the serum sialoproteins.
he RDE was inactivated by incubation with 2.5% sodium
itrate at 56°C, for 30 min. The twofold serial dilutions of
DE-treated sera were incubated with 0.5% human eryth-
ocyte saline suspension in the presence of agglutinat-
ng titers of influenza virus. The experiment was carried
ut in triplicate wells. After 45 min of incubation in 96-
ell round-bottom flexible plates (Falcon) at room tem-
erature, the results were read and expressed as end-
oint titers, corresponding to the highest dilution of sera
ssociated with inhibition of hemagglutination.
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